2021
June
May
April
March
February
January


2020
December
October
September
August
July
June
May
April
January


2019
November
September
August
June
May
March
February
January


2018
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Mar 11, 2021

ONE YEAR LATER: REVISTING A GREAT CONVERSATION THAT TOOK PLACE PRE-COVID RESTRICTIONS

Driven by her visionary passion and ceaseless curiosity, Mary Ann Liebert identifies and nurtures critical topics and cutting-edge fields by creating first-to-market, specialized publications that play a vital role in advancing research and facilitating collaboration in academia, industry, and government.

Mary Ann became interested in medical publishing when she was searching literature to try to find an effective treatment for her father’s Parkinson’s disease. In the late 1960s, it was a very unusual illness. Although she was not able to find a new drug or therapy to help her father, this research ignited her interest in medical publishing. Founded by Mary Ann Liebert in 1980, Mary Ann Liebert, Inc. is a leading independent publisher of scientific, technical, and medical content, known worldwide for its prescience and establishment of authoritative peer-reviewed journals, books, and trade publications in cutting-edge fields such as biotechnology, biomedical research, medicine and surgery, public health research and policy, technology and engineering, law, environmental research and policy, and other specialized disciplines. The company publishes over 90 peer-reviewed journals, leading trade magazines, and specialized newsletters, in addition to society membership management and conferences.

Mary Ann is deeply involved in the development and content of her more than 80 peer-reviewed scientific journals. Because of this she has extensive insight and interesting perspectives about many topics regarding medical innovation and practice. She has received numerous awards and accolades for her personal contributions in the fields of biotechnology and life sciences.

In this episode, we talk with Mary Ann about her career, her passions and the interesting medical topics covered by her 80 journals.